Published in Cancer Lett on June 05, 1996
Ewing's Sarcoma of the Head and Neck: A Retrospective Analysis of 24 Cases. Sarcoma (1999) 1.10
Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature. Sarcoma (2016) 0.83
Efficacy of Proton Beam Therapy in the Treatment of Ewing's Sarcoma of the Paranasal Sinuses and Anterior Skull Base. Skull Base (2009) 0.80
Primary extraskeletal Ewing's sarcoma of the maxilla with intraorbital extension. Indian J Otolaryngol Head Neck Surg (2007) 0.80
A rare case of primary Ewings sarcoma of the nasal bone. Indian J Otolaryngol Head Neck Surg (1998) 0.75
Ewing's sarcoma of maxilla: A rare case report. J Oral Maxillofac Pathol (2014) 0.75
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07
Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol (1991) 1.97
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol (1996) 1.67
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med (1998) 1.64
Optic nerve involvement in acute lymphoblastic leukemia. Leuk Lymphoma (1993) 1.52
Granular cell ameloblastoma: a case report with histochemical findings. Eur J Cancer B Oral Oncol (1996) 1.49
Dermoid cysts: 16-year survey. Ophthal Plast Reconstr Surg (1995) 1.44
Value of sonography in monitoring the therapeutic response of mediastinal lymphoma: comparison with chest radiography and CT. AJR Am J Roentgenol (1991) 1.44
Silencing the MET oncogene leads to regression of experimental tumors and metastases. Oncogene (2007) 1.42
Morphometric analysis of AgNORs in uveal malignant melanoma. Anal Quant Cytol Histol (1998) 1.39
A primary, lateral-cervical medullary thyroid carcinoma: a case report. J Clin Endocrinol Metab (1996) 1.38
Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart (2004) 1.31
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27
Vertebroplasty as treatment of aggressive and symptomatic vertebral hemangiomas: up to 4 years of follow-up. Neuroradiology (2009) 1.26
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa (2013) 1.13
Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res (2003) 1.13
Fine needle aspiration (FNA) biopsy of orbital masses: a critical review of 51 cases. Cytopathology (1997) 1.11
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res (1999) 1.08
An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature (2009) 1.07
Odontogenic myxoma: report of a case with peculiar features. J Oral Maxillofac Surg (1991) 1.06
Tricholemmal carcinoma: a study of seven cases. J Cutan Pathol (1992) 1.06
Survivin expression in oral squamous cell carcinoma. Br J Cancer (2003) 1.06
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther (2005) 1.05
Mediastinal tumors: biopsy under US guidance. Radiology (1989) 1.05
Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia? Acta Paediatr (2007) 1.05
Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial. J Clin Pharmacol (2001) 1.05
Primary monotypic epithelioid angiomyolipoma of bone. Histopathology (2002) 1.04
Mediastinal tumors: sensitivity of detection with sonography compared with CT and radiography. Radiology (1990) 1.04
Orbital venous-lymphatic malformations (lymphangiomas) mimicking cavernous hemangiomas. Am J Ophthalmol (2001) 1.04
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829. Cancer Res (1998) 1.03
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene (1997) 1.01
A case of mesonephric adenocarcinoma of the vagina with a 1-year follow-up. Int J Gynecol Cancer (2007) 1.00
Vertebroplasty and kyphoplasty: friends or foes? Radiol Med (2008) 0.97
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. Int J Pharm (2010) 0.97
Facial granulomatous diseases: a study of four cases tested for the presence of Mycobacterium tuberculosis DNA using nested polymerase chain reaction. Am J Dermatopathol (2001) 0.96
Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? Int J Immunopathol Pharmacol (2006) 0.95
Hemosiderotic dermatofibroma: report of one case. Dermatology (2007) 0.95
Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol (2001) 0.93
Dermatoscopic pitfalls in differentiating pigmented Spitz naevi from cutaneous melanomas. Br J Dermatol (1999) 0.92
New measurement of the antiproton-to-proton flux ratio up to 100 GeV in the cosmic radiation. Phys Rev Lett (2009) 0.92
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Br J Cancer (2007) 0.91
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease. Prostate Cancer Prostatic Dis (2005) 0.91
Pathologic explanation for hypoechoic halo seen on sonograms of malignant liver tumors: an in vitro correlative study. AJR Am J Roentgenol (1992) 0.91
Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma. Anticancer Res (2004) 0.91
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. Curr Cancer Drug Targets (2012) 0.91
PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints. Eur J Pharm Biopharm (2012) 0.91
Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases. Mod Pathol (1990) 0.90
Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression. Lab Invest (2001) 0.90
A comparison of minimally invasive techniques in percutaneous treatment of lumbar herniated discs. A review. Neuroradiol J (2009) 0.89
Fine-needle aspiration biopsies of breast masses. A critical analysis of 1956 cases in 8 years (1976-1984). Cancer (1988) 0.89
Prolactin secretion after beer. Lancet (1981) 0.89
Combined Percutaneous and Endovascular Treatment of Symptomatic Aneurysmal Bone Cyst of the Spine: Clinical Six Months. Follow-up of Six Cases. Neuroradiol J (2010) 0.89
Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging. Eur J Pediatr (1991) 0.89
Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? Histopathology (2007) 0.89
Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res (2000) 0.88
Vertebroplasty in the treatment of spine disease. Interv Neuroradiol (2006) 0.88
Estrogen receptor beta expression in human prostate tissue. Mol Cell Endocrinol (2001) 0.88
Thymoma: a clinico-pathologic study based on newly developed morphologic criteria. Tumori (1988) 0.87
HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma. Histol Histopathol (2004) 0.87
The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol (1996) 0.87
Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours. Histopathology (2003) 0.87
Left ventricle dimensions in preterm infants during the first month of life. Eur J Pediatr (2001) 0.87
Epithelioid hemangioendothelioma of the larynx. Tumori (2000) 0.86
Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. J Urol (1993) 0.86
Sinonasal lymphoma presenting as a lethal midline granuloma: case report. J Oral Maxillofac Surg (1998) 0.86
Acute cholestasis: atypical onset of Kawasaki disease. Dig Liver Dis (2007) 0.86
The distinction between benign and malignant liver tumors on sonography: value of a hypoechoic halo. AJR Am J Roentgenol (1992) 0.86
Liver resection in patients with eight or more colorectal liver metastases. Br J Surg (2015) 0.86
MASC is indistinguishable from acinic cell carcinoma, papillary-cystic variant on salivary gland FNA cytomorphology: case report with histological and immunohistochemical correlates. Cytopathology (2013) 0.85
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot study. Tumori (2001) 0.85
Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. J Clin Pathol (2004) 0.85
Prevalence of HCV antibodies in autoimmune thyroid disease. Eur Rev Med Pharmacol Sci (2006) 0.85
Echographic examination with new generation contrast agent of choroidal malignant melanomas. Acta Ophthalmol Scand (2005) 0.85
Role of tachykinins in the bronchoconstriction induced by HCl intraesophageal instillation in the rabbit. Life Sci (2003) 0.85
Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole. Mycoses (1997) 0.84
Salmonella brandenburg: a novel cause of acute suppurative thyroiditis. Acta Endocrinol (Copenh) (1993) 0.84
Peripheral ameloblastoma: report of a case with malignant aspect. Br J Oral Maxillofac Surg (1996) 0.84
Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection. J Clin Pathol (1998) 0.84
[Thoracic sarcoidosis]. Radiologe (1990) 0.84
Synchronous primary adenocarcinoma and adenosquamous carcinoma of the esophagus. Eur Radiol (2001) 0.84
An unusual orbital lesion: hepatoma metastatic to the orbit. Ophthalmologica (1994) 0.84
Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. Inflamm Res (1997) 0.84
Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med (1999) 0.84
Orbital dermis-fat graft using periumbilical tissue. Plast Reconstr Surg (2000) 0.84
Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis. Int J Oncol (2007) 0.84
Cyclooxygenase-2 expression in oral squamous cell carcinoma. Int J Immunopathol Pharmacol (2004) 0.84
Calcitriol plus hydrochlorothiazide prevents transient post-thyroidectomy hypocalcemia. Horm Metab Res (2006) 0.84
Spheno-orbital meningiomas: surgical approaches and outcome according to the intraorbital tumor extent. Zentralbl Neurochir (2008) 0.83
Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas. Cancer (2000) 0.83
Neurothekeoma of the thumb. A case report. Tumori (1988) 0.83
Cutaneous metastases from gastric adenocarcinoma. Report of two cases and review of the literature. Arch Anat Cytol Pathol (1996) 0.83
Characterization of 'faecal streptococci' as indicators of faecal pollution and distribution in the environment. Lett Appl Microbiol (1999) 0.83
Genetic analysis of oral squamous cell carcinoma by cDNA microarrays focused apoptotic pathway. Int J Immunopathol Pharmacol (2006) 0.83
Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene. Oncogene (1999) 0.83